Monopar Therapeutics

-$0.27 (-11.84%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MNPR and other ETFs, options, and stocks.

About MNPR

Monopar Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. engages in building a drug development pipeline through the licensing and acquisition of oncology therapeutics in late preclinical and clinical development stages. Its product pipeline includes Validive, Camsirubicin and MNPR-101.

CEO
Chandler Drew Robinson
Employees
10
Headquarters
Wilmette, Illinois
Founded
2014

MNPR Key Statistics

Market cap
25.37M
Price-Earnings ratio
—
Dividend yield
—
Average volume
13.50K
High today
$2.34
Low today
$2.02
Open price
$2.26
Volume
16.85K
52 Week high
$6.98
52 Week low
$1.70

MNPR Earnings

-$0.22
-$0.15
-$0.07
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure